Related references
Note: Only part of the references are listed.Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis
Sara Galastri et al.
CLINICAL SCIENCE (2012)
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
Christer Baeck et al.
GUT (2012)
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
Vlad Ratziu et al.
HEPATOLOGY (2012)
Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease
Anita Pathil et al.
HEPATOLOGY (2012)
Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos
Dominick J. Lemas et al.
JOURNAL OF LIPID RESEARCH (2012)
A New Model of Interactive Effects of Alcohol and High-Fat Diet on Hepatic Fibrosis
Erwin Gaebele et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2011)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Loss of Caspase-8 Protects Mice Against Inflammation-Related Hepatocarcinogenesis but Induces Non-Apoptotic Liver Injury
Christian Liedtke et al.
GASTROENTEROLOGY (2011)
Prevalence, gender, ethnic variations, and prognosis of NASH
Etsuko Hashimoto et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-Fed db/db mice
Kanji Yamaguchi et al.
LABORATORY INVESTIGATION (2011)
Role of Cytokines in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
Subir Kumar Das et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2011)
Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity
Damir Zadravec et al.
FASEB JOURNAL (2010)
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Brad Q. Starley et al.
HEPATOLOGY (2010)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Effect of Dietary Monosodium Glutamate on HFCS-Induced Hepatic Steatosis: Expression Profiles in the Liver and Visceral Fat
Kate S. Collison et al.
OBESITY (2010)
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Jacqueline Bromberg et al.
CANCER CELL (2009)
Pan-Caspase Inhibitor VX-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis
Rafal P. Witek et al.
HEPATOLOGY (2009)
Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2008)
Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies
Paul J. Pockros et al.
JOURNAL OF HEPATOLOGY (2007)
CCAAT/enhancing binding protein β deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis
Shaikh Mizanoor Rahman et al.
HEPATOLOGY (2007)
Role of caspase-8 in hepatocyte response to infection and injury in mice
Tehila Ben Moshe et al.
HEPATOLOGY (2007)
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2007)
Caspase-8 dependent trail-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase
Isabel Perez-Cruz et al.
APOPTOSIS (2007)
Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis
MW Bradbury
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse
A Canbay et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance
ME Rinella et al.
JOURNAL OF HEPATOLOGY (2004)
Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses
T Takehara et al.
GASTROENTEROLOGY (2004)
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein et al.
GASTROENTEROLOGY (2003)
Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis
A Canbay et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Caspase 8 small interfering RNA prevents acute liver failure in mice
L Zender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Fas enhances fibrogenesis in the bile duct ligated mouse: A link between apoptosis and fibrosis
A Canbay et al.
GASTROENTEROLOGY (2002)
The utility of radiological imaging in nonalcoholic fatty liver disease
S Saadeh et al.
GASTROENTEROLOGY (2002)
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
AJ Sanyal et al.
GASTROENTEROLOGY (2001)
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
IA Leclercq et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
